Français
ItalianoBond Bausch Health Group 7% ( USU9098VAE21 ) in USD
| Issuer | Bausch Health Group |
| Market price | 100 % ⇌ |
| Country |  Canada
|
| ISIN code |
 USU9098VAE21 ( in USD )
|
| Interest rate | 7% per year ( payment 2 times a year) |
| Maturity | 30/09/2020 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 700 000 000 USD |
| Cusip | U9098VAE2 |
| Standard & Poor's ( S&P ) rating | N/A |
| Moody's rating | N/A |
| Detailed description |
Bausch Health Companies is a global pharmaceutical company focused on developing, manufacturing, and marketing a range of pharmaceutical, ophthalmological, and consumer healthcare products. A notable fixed-income instrument, identified by ISIN USU9098VAE21 and CUSIP U9098VAE2, was issued by Bausch Health Companies Inc., a prominent multinational pharmaceutical company based in Canada, specializing in the development, manufacturing, and marketing of a diverse range of pharmaceutical products across areas such as eye health, gastroenterology, and dermatology. This specific bond, denominated in USD, bore an annual interest rate of 7%, with semi-annual interest payments, and represented a total issuance size of $700,000,000, available for purchase in minimum increments of $2,000. Originating from Canada, this financial instrument successfully reached its maturity date on September 30, 2020, and has since been fully redeemed and reimbursed at its par value, consistent with its final market quotation of 100% before its scheduled repayment. |